Home

Blog

H.R. 5651, The Food and Drug Administration Reform Act of 2012 (4 wiki edits: view article ↓)

  • This item is from the 112th Congress (2011-2012) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.

H.R. 5651 would amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to establish user-fee programs for generic drugs and biosimilars.

(read more ↓)
[18 views]

Costs: $115.55 per
and increases their $162,301.27 share of the national debt by $1.90.
(source: Congressional Budget Office)

From the Blog

WashingtonWatch.com Digest – May 29, 2011

This is the WashingtonWatch.com email newsletter for the week of May 28, 2011. Subscribe (free!) here. email newsletter | tell a friend | wiki | about | home | log in On the Blog: Homeland Security Spending New cost estimates for a couple of bills prov...

Visitor Comments Comments Feed for This Bill

There are currently no comments for this bill

RSS Feeds for This Bill

Keep yourself updated on user contributions and debates about this bill! (Learn more about RSS.)